📢 ASPIRE Quarterly Webinar Elevating Patient Voices & Management of #irAEs 📆 Tues 9/22 · 4:00–5:30 PM ET 🎤 Drs. Laura Petrillo @lpetrillz, Jasmin Tiro, Matthias Villalobos 🎯 Moderated by Drs. @KMittalmd & @afreenshariffmd 💻 Zoom🔗: us.list-manage.com/1B14TXB1R… #Oncology
1
2
281
ASPIRE, a community of practice of @ASCO is proud to present a virtual webinar on Elevating Patient Voices in the Management of irAEs. Join us today at 4 pm EST for our Quarterly Webinar series with hosts @KMittalmd and @afreenshariffmd 🔗 in flyer ⬇️
📢 ASPIRE Quarterly Webinar Elevating Patient Voices & Management of #irAEs 📆 Tues 9/22 · 4:00–5:30 PM ET 🎤 Drs. Laura Petrillo @lpetrillz, Jasmin Tiro, Matthias Villalobos 🎯 Moderated by Drs. @KMittalmd & @afreenshariffmd 💻 Zoom🔗: us.list-manage.com/1B14TXB1R… #Oncology
1
2
118
Residents & fellows: how are you learning about immune-related adverse events? ⏱️ 5 minutes 🔒 Anonymous ✅ No right or wrong answers Help ASPIRE's Community Education Committee build better irAE education 👇
1
6
799
🚨 Aug 18: ASPIRE case discussion on immunotherapy toxicity 🧠 Neuro — John Probasco, MD (Hopkins) 🩹 Skin — Silvina Pugliese, MD (NYU) Moderators: Aliyah Pabani, MD & Stephane Champiat, MD, PhD 5:30–6:30 PM CST | CME 51508 tinyurl.com/yck5afku #irAE #Oncology @KMittalmd
1
1
1
1,165
In case you missed this- link will be in our upcoming newsletter- stay tuned!
14
ASPIRE Community of Practice retweeted
Replying to @ASPIRE_CoP
@ASPIRE_CoP members please take note!
🚨irAE aficianados! Open comment for Renal, Musculoskeletal, and Cardiac adverse events sections of the @ASCO irAE guidelines are now available through August 28th at: asco1.qualtrics.com/jfe/form… As everything with irAE, it's a team sport. We want to hear your comments!

ALT Strike Shout GIF by Deutscher Gewerkschaftsbund (DGB)

1
1
301
Please share with your trainees- to help us design evidence based education pertaining to irAEs. cc: @DrKarineTawagi @ASridharMD @NazliDizman @FunchainMD @PGrivasMDPhD
2
5
1,637
Happening now- join us for our quarterly webinar!
2
117
⏰ Starting in 15 minutes! Join ASPIRE's webinar "ASCO Highlights in irAEs: Key Abstracts & Clinical Takeaways" — 4 PM EST with our expert panel. Hop on 👉 shorturl.at/B2zt2 #irAE #immunotherapy #oncology
2
82
Glad to see some of our Executive Committee members on this- @ASPIRE_CoP remains committed to fostering a community of #irAE clinicians, educators and researchers! @FunchainMD @thenasheffect
Today's @sitcancer program on immunotherapy toxicity management felt less like a webinar and more like a conversation among colleagues. #irAEs remain one of the areas where clinical experience is often ahead of the evidence, making discussions like these particularly valuable. A pleasure to share the session with such a great faculty panel and many friends across the field. @kreynoldsMD @thenasheffect @EladSharonMD @FunchainMD @LKottschadeCNP Ryan Sullivan, Matthew Lei, Aleksandra Kukla. Thanks to @sitcancer for the invitation and the discussion! @Surgeon_General @CampusBioMedico @PoliclinCampus
1
1
4
461
Here’s a 🔗 to the newsletter mailchi.mp/1e6c4c8aed14/f9hi… Don’t forget to log in for our June 17 ASCO irAE webinar!
📬 The latest ASPIRE June Newsletter is here! Inside: our back by popular-demand curated #irAE abstracts list, #ASCO26 meeting highlights & more. ⭐ Don't miss our June 17 webinar — "ASCO Highlights in irAEs: Key Abstracts & Clinical Takeaways" 4 PM EST with an expert panel
2
387
📬 The latest ASPIRE June Newsletter is here! Inside: our back by popular-demand curated #irAE abstracts list, #ASCO26 meeting highlights & more. ⭐ Don't miss our June 17 webinar — "ASCO Highlights in irAEs: Key Abstracts & Clinical Takeaways" 4 PM EST with an expert panel
2
2
306
ASPIRE Community of Practice retweeted
If you are a resident or fellow (in any specialty) please consider taking this survey to help ASPIRE develop #irAE and IOTOX education resources for medical trainees @FunchainMD @ASridharMD @DrKarineTawagi @mhadfield30 @OncBrothers @OncoAlert
4
5
2,678
If you are a resident or fellow (in any specialty) please consider taking this survey to help ASPIRE develop #irAE and IOTOX education resources for medical trainees @FunchainMD @ASridharMD @DrKarineTawagi @mhadfield30 @OncBrothers @OncoAlert
📢 Residents & Fellows: Help shape the future of immunotherapy education! Participate in our 5-min anonymous survey on #irAE experiences.🩺 Program directors and faculty—please share with your trainees! Complete the survey:🔗 shorturl.at/GMNMY #ASPIRECOP #OncMedEd
4
2,295
Couldn't catch every #irAE session at #ASCO26? We've got you! 🧡 Join @ASPIRE_CoP, @FunchainMD, @mhadfield30, @LZubiriOteiza & Dr. Pabani for ASPIRE's post-ASCO webinar 📅 June 17, 4 PM EST Free to join 👉shorturl.at/B2zt2 #immunotherapy
1
2
3
1,294
ASPIRE Community of Practice retweeted
🚨irAE aficianados! Help shape @ASCO guidelines in part 1 of open comment on the next iteration of ASCO's irAE guidelines. Open for comment until Wed 6/10 ✍️ Part 1: 🫁👁️👄 Link to comment here 👇 asco1.qualtrics.com/jfe/form…
1
6
18
950
Live at #ASCO26: "Advancing ICI Therapy in High-Risk Populations" — rechallenge, transplant & combo toxicity. 📍E450a 🕖 4:45 - 6:00 PM CDT Takeaway: @MattCarlino  #immunotherapy #irAE
1
1
2
501
🔥 Exciting sessions to watch out for at #ASCO26! 🛡️ High-risk patients deserve immunotherapy too. How do we get them there safely? 📋 Advancing ICI Therapy in High-Risk Populations 🗓️ Mon Jun 1 🕖4:45–6:00 PM CT 📍 Room E450a #irAEs #immunotherapy
1
80
Big morning for #irAE research at #ASCO26 📍Hall A is full of it! A few we're watching: ICI rechallenge after irAE (#11127), CAR-T thyroid toxicity  (#11148), and pan-cancer genomic drivers of irAEs (#11132). Go see them!
3
4
195
A question for the #ASCO26 community: biggest unmet gap in managing checkpoint inhibitor pneumonitis? #irAE
0% Earlier recognition
100% Steroid-sparing options
0% Rechallenge decisions
0% Multidisciplinary care
1 votes • Final results
3
4
247